<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the long-term cost-effectiveness of aspirin use among adults aged &gt;or=40 years with newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We used a validated cost-effectiveness model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to assess the lifetime health and cost consequences of use or nonuse of aspirin </plain></SENT>
<SENT sid="2" pm="."><plain>The model simulates the progression of <z:mp ids='MP_0002055'>diabetes</z:mp> and accompanying complications for a cohort of subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The model predicts the outcomes of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> along five disease paths (<z:hpo ids='HP_0000112'>nephropathy</z:hpo>, <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, and <z:hpo ids='HP_0001297'>stroke</z:hpo>) from the time of diagnosis until age 94 years or until <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Over a lifetime, aspirin users gained 0.31 life-years (LY) or 0.19 quality-adjusted LYs (QALYs) over nonaspirin users, at an incremental cost of $1,700; the incremental cost-effectiveness ratio (ICER) of aspirin use was $5,428 per LY gained or $8,801 per QALY gained </plain></SENT>
<SENT sid="5" pm="."><plain>In probabilistic sensitivity analyses, the ICER was &lt;$30,000 per QALY in <z:hpo ids='HP_0000001'>all</z:hpo> of 2,000 realizations in two scenarios </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Regular use of aspirin among people with newly diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> is cost-effective </plain></SENT>
</text></document>